Precision Medicine

Imagine a world where cancer treatment is no longer a grueling, one-size-fits-all ordeal, but a finely tuned process designed specifically for each patient’s unique biology, marking a seismic shift from traditional approaches like chemotherapy and radiation that often cast a wide net with

Leishmaniasis, a debilitating infectious disease caused by the protozoan parasite Leishmania , continues to afflict millions of people worldwide, predominantly in under-resourced regions where access to effective healthcare remains a significant challenge. Among its numerous species, Leishmania

Glioblastoma, recognized as the most aggressive and common form of brain cancer, especially in its IDH wild-type variant, remains a daunting challenge with survival rates often limited to about a year despite intensive treatments like surgery, radiotherapy, and chemotherapy. A groundbreaking study

In the heart of Omaha, Nebraska, the University of Nebraska Medical Center (UNMC) is quietly transforming the landscape of cancer treatment through its pioneering work in precision oncology, proving that geographic location is no barrier to innovation. Far from the bustling medical hubs of the East

Imagine a diagnostic tool so advanced that it can uncover hidden threats within the thyroid gland, even when masked by a complex inflammatory condition. A groundbreaking study has brought this vision to life by developing a radiomics model based on nonenhanced computed tomography (NECT) scans to

What happens when a traumatic brain injury (TBI) strikes, leaving millions grappling with invisible damage that traditional medicine struggles to detect or treat? In emergency rooms and clinics worldwide, this silent epidemic affects over 60 million people annually, often leading to lifelong